» Articles » PMID: 11295647

Total and Specific IgE in Nasal Polyps is Related to Local Eosinophilic Inflammation

Overview
Date 2001 Apr 11
PMID 11295647
Citations 173
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nasal polyps (NPs) are characterized by eosinophilic inflammation and often coexist with asthma. However, the role of atopy and IgE in NP pathogenesis is unclear.

Objective: We sought to determine whether there is an association between total and specific IgE to a variety of allergens in polyp and nonpolyp tissue and markers of eosinophilic inflammation or skin test results.

Methods: Homogenates were prepared from nasal tissue of 20 patients with NPs and 20 patients without NPs and analyzed for concentrations of IL-5, IL-4, eotaxin, leukotriene (LT) C4/D4/E4, sCD23, and histamine (ELISA). Eosinophil cationic protein (ECP), tryptase, and total and specific IgE for inhalant allergens and Staphylococcus aureus enterotoxins were measured (ImmunoCAP).

Results: The concentrations of total IgE, IL-5, eotaxin, ECP, LTC4/D4/E4, and sCD23 were significantly higher in NP tissue compared with nonpolyp tissue. Total IgE was significantly correlated to IL-5, ECP, LTC4/D4/E4, and sCD23 and to the number of eosinophils in NPs. On the basis of the presence of specific IgE antibodies in tissue, 3 NP groups were defined. NP group 1 demonstrated no measurable specific IgE, and NP group 2 selected specific IgE. The third group demonstrated a multiclonal specific IgE, including IgE to S aureus enterotoxins, a high total IgE level, and a high prevalence of asthma.

Conclusions: These studies suggest that there is an association between increased levels of total IgE, specific IgE, and eosinophilic inflammation in NPs, which may be of relevance in the pathophysiology of nasal polyposis. Similarly, the presence of specific IgE to staphylococcal enterotoxins A and B also points to a possible role of bacterial superantigens.

Citing Articles

Type 2 immunity in allergic diseases.

Ogulur I, Mitamura Y, Yazici D, Pat Y, Ardicli S, Li M Cell Mol Immunol. 2025; 22(3):211-242.

PMID: 39962262 PMC: 11868591. DOI: 10.1038/s41423-025-01261-2.


The Role of Nasal Microbiota and Sensitivity in Patients With Chronic Rhinosinusitis at a Rural Tertiary Care Hospital.

Suriya Luke Rathnakumar B, Gowda U, Guttal C, Gautham S Cureus. 2025; 16(12):e76048.

PMID: 39834958 PMC: 11743748. DOI: 10.7759/cureus.76048.


Risk factors for postoperative relapse of chronic rhinosinusitis with nasal polyps and improvement in clinical treatment.

Wang W, Fu J, Chang W Am J Transl Res. 2025; 16(12):7609-7617.

PMID: 39822494 PMC: 11733391. DOI: 10.62347/CHQV3614.


Chronic Rhinosinusitis With Nasal Polyps Does Not Affect the Association Between the Nasal Provocation Test and Serum Allergen-Specific Immunoglobulin E Levels.

Yoon H, Kwak I, Kim K, Min H J Rhinol. 2024; 31(1):29-36.

PMID: 39664038 PMC: 11566544. DOI: 10.18787/jr.2024.00004.


Comparison of Eosinophil Profile and Lund Kennedy Score in Patients with Nasal Polyps.

Maqsood R, Gul S, Malik J, Ali I Indian J Otolaryngol Head Neck Surg. 2024; 76(6):5542-5548.

PMID: 39559105 PMC: 11569289. DOI: 10.1007/s12070-024-05026-7.